
NAMS Stock Price Prediction
NewAmsterdam Pharma Company NV
- Overview
- Forecast
- Valuation
- Earnings
1-Day-Price-Prediction
+0.51%
1-Week Prediction
+2.78%
Based on our advanced algorithm, we predict that NAMS stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $22.54, while the 1-week outlook suggests a value of $23.05. For the 1-month forecast, we project a price of $22.91. Looking further ahead, our 2026 projection estimates a value of $41.82, with a long-term 2030 forecast reaching $520.42. Stay informed and make strategic decisions with our data-driven insights!
22.910
Should I Buy NewAmsterdam Pharma Company NV Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NAMS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
NAMS stock price ended at $22.43 on Wednesday, after losing -1.54%
The NewAmsterdam Pharma Company NV stock price decreased by -1.54% on the last trading day (30 Jul 2025), dropping from 23.36 to 22.43. Throughout the last trading session, the stock experienced a fluctuation of 9.47% , ranging from a day low of $21.55 to a day high of 23.59. The price has declined in 4 of the last 10 days, resulting in a total change of 7.22% during this period. On the last day, trading volume decrease by 547.57K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.19M shares were traded, amounting to approximately 26.81M.
NAMS Technical Signals
NAMS(NewAmsterdam Pharma Company NV Corp) has 3 buy signals and 1 sell signal now. The current trend is uptrend starting from 2025-07-17. The total price change during this trend is +2.05%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of NAMS over the last 5 trading days is 17.96M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.

Get winning stock picks in minutes
NAMS Moving Average Analysis
NewAmsterdam Pharma Company NV's overall moving average trend leans more bearish as of Thursday, July 31, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $25.41, and $27.05. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $20.11, and $18.47. A break-down below any of these levels will issue sell signals.
NAMS Short Selling Analysis
The short sale ratio of NewAmsterdam Pharma Company NV(NAMS) as of 28 Jul 2025 is 27.12%, rising from last trading day. With increasing price from 23.60 to 23.42. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary

Buy
Sell
1
Buy
3
Moving Average
Swing

Stock Price Below SMA_5
Short Term

SMA_5 Above SMA_20
Mid Term

SMA_20 Above SMA_60
Long Term

SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
2.593
Bullish
Momentum (10 days)
MOM_10 > 0
1.51
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.975
Bullish
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Moving Average
Price crosses below 10-day SMA
--
Bearish
NAMS Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, NewAmsterdam Pharma Company NV (NAMS) is anticipated to change hands in a trading channel between $24.13 and $49.82.
NewAmsterdam Pharma Company NV Stock Forecast 2026
Jan 2026: NAMS Stock Forecast
Potential ROI: 70.74%
In Jan 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $31.30. The price is predicted to fluctuate between a low of $27.03 and a high of $32.14.
Feb 2026: NAMS Stock Forecast
Potential ROI: 66.54%
In Feb 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $30.53. The price is predicted to fluctuate between a low of $24.13 and a high of $39.21.
Mar 2026: NAMS Stock Forecast
Potential ROI: 92.27%
In Mar 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $35.24. The price is predicted to fluctuate between a low of $34.40 and a high of $38.27.
Apr 2026: NAMS Stock Forecast
Potential ROI: 84.03%
In Apr 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $33.73. The price is predicted to fluctuate between a low of $25.15 and a high of $37.64.
May 2026: NAMS Stock Forecast
Potential ROI: 102.58%
In May 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $37.13. The price is predicted to fluctuate between a low of $33.82 and a high of $41.10.
Jun 2026: NAMS Stock Forecast
Potential ROI: 99.59%
In Jun 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $36.58. The price is predicted to fluctuate between a low of $28.80 and a high of $36.59.
Jul 2026: NAMS Stock Forecast
Potential ROI: 128.15%
In Jul 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.82. The price is predicted to fluctuate between a low of $40.50 and a high of $47.60.
Aug 2026: NAMS Stock Forecast
Potential ROI: 111.40%
In Aug 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $38.75. The price is predicted to fluctuate between a low of $38.53 and a high of $43.55.
Sep 2026: NAMS Stock Forecast
Potential ROI: 125.10%
In Sep 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.26. The price is predicted to fluctuate between a low of $36.68 and a high of $44.89.
Oct 2026: NAMS Stock Forecast
Potential ROI: 79.36%
In Oct 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $32.88. The price is predicted to fluctuate between a low of $24.81 and a high of $41.42.
Nov 2026: NAMS Stock Forecast
Potential ROI: 128.15%
In Nov 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.82. The price is predicted to fluctuate between a low of $33.96 and a high of $49.82.
Dec 2026: NAMS Stock Forecast
Potential ROI: 124.53%
In Dec 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.16. The price is predicted to fluctuate between a low of $33.82 and a high of $42.47.

Get winning stock picks in minutes
NAMS Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to NewAmsterdam Pharma Company NV(NAMS), our algorithm predicts NAMS's 1-month price at $22.80, with an -3.38%downwardshift. Using a similarity score up to 97.69%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for NewAmsterdam Pharma Company NV (NAMS.O) stock, as of Sunday, July 27, 2025 , forecasts a -3.38% change over the next month, based on its high correlation with CPRX.O stock patterns. The similarity between their price movements over the analyzed periods is 97.69%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

NAMS
Future prediction
Up: -3.38%


Full Access. No Commitment.
7 Days Free!
AI Stock Picker
AI Swing Trade Signal
AI Earning Prediction
AI Screener
AI Financial Agent Help You Do Research
Already have an account? Sign In Here

CPRX
Down: -3.38%Similarity: 97.69%
Name
Similarity
Up/Down

CPRX.O
97.69%
-3.38%

UCB.N
97.55%
-12.56%

USAC.N
97.40%
+10.89%

CIGI.O
97.34%
+6.40%

RGR.N
97.34%
-3.14%

HLT.N
97.23%
+1.81%

WNS.N
97.20%
+8.40%

SBCF.O
97.20%
-6.38%

UL.N
97.19%
+2.77%

DLB.N
97.18%
+2.82%
NAMS Seasonality Analysis
Based on NAMS's historical stock price data across all years, the probability of a positive return in July is40.00%, suggesting it maynotbe an ideal month to invest in NAMS. In contrast,Januaryoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying NewAmsterdam Pharma Company NV (NAMS.O) stock in January has the highest probability of a positive return (75.00%), while May has the lowest probability (0.00%).
Performance Seasonality
The chart shows NewAmsterdam Pharma Company NV. (NAMS)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

AMR
Alpha Metallurgical Resources Inc
119.290
USD
-5.38%

SIG
Signet Jewelers Ltd
78.850
USD
-3.10%

CALX
Calix Inc
56.870
USD
+1.19%

HCM
HUTCHMED (China) Ltd
18.310
USD
-4.69%

FLYW
Flywire Corp
11.140
USD
-3.88%

CURB
Curbline Properties Corp.
22.430
USD
-2.22%

NEOG
Neogen Corp
4.695
USD
-2.80%

CAKE
Cheesecake Factory Inc
66.470
USD
+5.21%

EWTX
Edgewise Therapeutics Inc
14.230
USD
+2.01%

SBSW
Sibanye Stillwater Ltd
8.550
USD
-6.56%
FAQ

Should I buy NewAmsterdam Pharma Company NV (NAMS.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NAMS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

Which months have the highest win rate for buying NewAmsterdam Pharma Company NV (NAMS.O) stock in a year?

How has NewAmsterdam Pharma Company NV. (NAMS)'s stock price performed over the past three years?

Which bull technical signals does NAMS have?

Which bearish technical signals does NAMS have?

Is NAMS a buy based on overall technical signals summary?

What is the trend of NewAmsterdam Pharma Company NV (NAMS)'s moving average?

What is price prediction for NAMS stock next month?

What is price prediction 2025 for NAMS Stock?
